BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Clinical Research

Telix Doses First US Patient In Phase Three BiPASS Prostate Cancer Imaging Trial

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") announces that the first patient in the United States (U.S.) has been dosed in BiPASS&...

January 20, 2026 | News

Harbour BioMed Strengthens Strategic Ties With Spruce Biosciences Through Equity Stake

Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in imm...

January 20, 2026 | News

D3 Bio Secures FDA IND Clearances To Advance KRAS G12D And G12C Clinical Programme

D3 Bio, a global clinical‑stage biotechnology company focused on developing transformative oncology therapeutics, announced that the U.S. Foo...

January 20, 2026 | News

Dr Chris Chen Positions WuXi Biologics As The Defining Force Shaping The Future Of Global CRDMO Innovation

Total of 945 integrated projects in 2025, including 74 Phase III clinical projects and 25 commercial manufacturing projects 209 new integrated projects ...

January 19, 2026 | News

GCCL and OPIS Announce Strategic Collaboration to Advance Global Clinical Trial Capabilities

GCCL, a leading South Korea-based provider of clinical trial sample analysis, and OPIS, a global full-service contract research organization (CR...

January 19, 2026 | News

Thermo Fisher Scientific Introduces Invitrogen TaqMan Cells To CT HepatoExpress Kit For Faster Liver Based Gene Expression Analysis

Thermo Fisher Scientific has launched the Invitrogen TaqMan Cells to CT HepatoExpress Kit, a new solution designed to simplify and accele...

January 16, 2026 | News

Immunofoco CAR T Therapy IMC002 Posts Strong Responses In Advanced Gastric And Gej Cancers At Asco Gi 2026

Immunofoco, a clinical-stage biotechnology company advancing innovative CAR-T cell therapies for solid tumors, recently announced clinical data from ...

January 15, 2026 | News

ElpasBio And Fosun Kairos Partner To Commercialise AlloJoin Stem Cell Therapy For Knee Osteoarthritis In Greater China

ElpasBio Holdings ("ElpasBio"), a leading clinical-stage biotechnology company focused on regenerative medicine, announced that it has entered into a colla...

January 15, 2026 | News

Animate Biosciences Delivers Ai Designed Peptides That Match Standard Of Care In Pulmonary Fibrosis Model

Animate Biosciences announces positive preclinical results from a mouse model of pulmonary fibrosis demonstrating that two of its AI-designed therapeu...

January 15, 2026 | News

Novartis Secures Worldwide Licence To PepLib Peptide Asset To Expand Radioligand Therapy Pipeline

Zonsen PepLib Biotech Inc. announced that it has entered into a worldwide license agreement with Novartis for an undisclosed peptide-based asset in t...

January 15, 2026 | News

Allele Joins Arpa H Programme To Bioprint Patient Specific Livers With Uc San Diego

Allele Biotechnology & Pharmaceuticals, Inc. (Allele), a San Diego-based technology development and cell manufacturing company, announced its par...

January 15, 2026 | News

Aptar Powers Intranasal Covid Vaccine Trial With LuerVax And Spray Divider Delivery Systems

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery and consumer product dosing, dispensing and protection technologies, announced that its inno...

January 15, 2026 | News

TetraScience And Thermo Fisher Join Forces To Accelerate Scientific AI Across Biopharma

TetraScience, the Scientific Data and AI company, announced a collaboration with Thermo Fisher Scientific Inc., the world leader in serving science, with a...

January 14, 2026 | News

Thermo Fisher And NVIDIA Join Forces To Build The AI Powered Laboratory Of The Future

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced a strategic collaboration with NVIDIA to power AI-based solutions...

January 13, 2026 | News

Stay Connected